Each molecule requires custom formulation to maximize the quality of its delivery.

Since our philosophy is to forge a productive association and a successful collaboration with our partners, we are convinced that in order to save a huge amount of money and time, any transfer of technology should be planned before phase IIa, when it would be too late to correct any potential problem.

Thus a close and early collaboration is necessary to insure a successful drug delivery formulation, which will fullfil your expectations.

We believe that the best way to maximise our common strategy is to start with a low cost initial feasibility study (see “Processes of Evaluation”) that may, then, proceed to a full project on the basis of several go/no-go decision steps.